Analgesic
Tapentadol
search
Tapentadol
, Nucynta
Mechanism
Mu-
Opioid
receptor
Agonist
Norepinephrine
reuptake inhibitor
Indications
Moderate to severe acute pain
Contraindications
Severe renal
Impairment
Severe hepatic
Impairment
Efficacy
As effective as
Oxycodone
Less
Nausea
,
Vomiting
and
Constipation
than
Oxycodone
Drug Interactions
Serotonin Syndrome
risk
Adverse Reactions
Seizure
s
Anaphylactoid Reaction
Respiratory Depression
Preparations
Schedule II Controlled Substance
Immediate release
Tapentadol 50-100 mg orally every 4-6 hours as needed (up to 600 mg/day)
Decrease dose to 50 mg every 8 hours if moderate hepatic
Impairment
Extended release
Tapentadol XR 50 mg orally twice daily (and titrate up to 250 mg twice daily)
May start higher if transitioning from other
Opioid
s
References
Tarascon pharmacopeia (2013)
Hartrick (2011) CNS Drugs 25(5): 359-70 [PubMed]
Type your search phrase here